Partition Bio is a biotechnology company that focuses on developing technologies related to membraneless organelles (MLOs) for cellular physiology and organization. The company aims to apply their understanding of LLPS (Liquid-Liquid Phase Separation) to address dysfunctions associated with MLOs, including neurodegenerative diseases, cancers, and viral infections.

Partition Bio

PartitionBio  
Exploiting a novel proprietary technology platform to develop biomolecular tools for the use in therapeutic and synthetic biology applications.

contact@partitionbio.co.uk

PartitionBio Ltd

𝐏𝐚𝐫𝐭𝐢𝐭𝐢𝐨𝐧𝐁𝐢𝐨 𝐚𝐰𝐚𝐫𝐝𝐞𝐝 𝐠𝐫𝐚𝐧𝐭 𝐭𝐨 𝐞𝐱𝐩𝐥𝐨𝐢𝐭 𝐢𝐭𝐬 𝐧𝐨𝐯𝐞𝐥 𝐛𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐬𝐡𝐮𝐭𝐭𝐥𝐞 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦 𝐟𝐨𝐫 𝐭𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜 𝐧𝐮𝐜𝐥𝐞𝐢𝐜 𝐚𝐜𝐢𝐝𝐬 𝐝𝐞𝐥𝐢𝐯𝐞𝐫𝐲 
PartitionBio received a grant from the Bill & Melinda Gates Foundation to utilise its proprietary biocondensate-based macromolecule delivery platform for the transfection of cells with nucleic acids. The purpose of the project is to deploy the breakthrough technology as a novel non-viral tool for the introduction of protein-encoding RNA or DNA into human cells. The long-term aim of the work is to enable a more efficient approach for the expression of therapeutic proteins in patients.


𝐀𝐛𝐨𝐮𝐭 𝐏𝐚𝐫𝐭𝐢𝐭𝐢𝐨𝐧𝐁𝐢𝐨
PartitionBio is a Cambridge (UK) based biotech start-up company offering a revolutionary technology platform for the non-viral delivery of a broad spectrum of macromolecules with therapeutic potential across the cell membrane. Possible payloads for the shuttle condensates include antibodies, proteins, peptides and nucleic acids.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 31, 2024 1:41 AM	8547f9a8
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	836ca66c
crunchbase profile	general
li profile	general	Aug 31, 2024 1:41 AM	4d8af64c
translate crunchbase fundingrounds	general
peers	general	Aug 31, 2024 1:41 AM	5e7ab798
news basic	general	Aug 31, 2024 1:41 AM	fb032721
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

CO

UK:CO:PARTITIONBIO

Partition Bio